An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies

Trial Overview

Am I Eligible?

Participating US Centers

University of Kansas Cancer Center

This center is currently accepting patients.

Kansas City, KS


Mayo Clinic

This center is currently accepting patients.

Jacksonville, FL


Fred Hutchinson Cancer Research Center

This center is currently accepting patients.

Seattle, WA


UW Carbone Cancer Center
University of Wisconsin Health

This center is currently accepting patients.

Madison, WI


Loyola University Medical Center
Cardinal Bernardin Cancer Center

This center is currently accepting patients.

Maywood, IL


University of Rochester Medical Center
James P. Wilmot Cancer Center

This center is currently accepting patients.

Rochester, NY


Northwestern Medicine Cancer Center Warrenville

This center is currently accepting patients.

Warrenville, IL


Ochsner Medical Center

This center is currently accepting patients.

Jefferson, LA


Greenville Memorial Hospital
Greenville Health System

This center is currently accepting patients.

Greenville, SC


Redlands Community Hospital

This center is currently accepting patients.

Redlands, CA

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 2

Trial Enrollment

80 sparks required

Trial Sponsors
  • Cellectar Biosciences
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;